The Use of Interleukine-1 Inhibitors in Familial Mediterranean Fever Patients: A Narrative Review.

Frontiers in Immunology
Véronique HentgenSophie Georgin-Lavialle

Abstract

Purpose: Familial Mediterranean fever (FMF) is the most common monogenic auto-inflammatory disease characterized by recurrent attacks of fever and serositis. It is associated with mutation in pyrin inflammasome leading to interleukin-1 (IL-1) over secretion. Although colchicine is the first line treatment in FMF, 5-10% of patients are reported in literature as non-responders. Colchicine is not always well-tolerated due either to its direct toxicity or to co-morbidities that preclude the administration of its proper dosage. For these patients an alternative or additional treatment to colchicine is necessary. This literature review reports the published data regarding the use of IL-1 inhibitors in Familial Mediterranean Fever. Results: There is no uniform definition of colchicine resistance, but the different studies of treatment with IL-1 inhibitors provide evidence of IL-1 pathogenic role in colchicine-resistant FMF. IL-1 inhibition is an efficacious option for controlling and preventing flares -at least at the short term- in FMF patients who are insufficiently controlled with colchicine alone. Although canakinumab is the only approved drug in Europe for colchicine resistant FMF treatment, experience with anakinra is also subst...Continue Reading

References

Jun 18, 1987·The New England Journal of Medicine·R W KunclM Peper
Apr 17, 1986·The New England Journal of Medicine·D ZemerJ Gafni
Oct 31, 1974·The New England Journal of Medicine·C A DinarelloD W Alling
Oct 1, 1996·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·J J MontsenyR K Gherardi
Sep 1, 1997·Nature Genetics·UNKNOWN French FMF Consortium
Mar 21, 1998·Lancet·E Ben-Chetrit, M Levy
May 16, 2002·Clinical Transplantation·Mehmet Riza AltiparmakEkrem Erek
Jul 1, 1958·A.M.A. Archives of Internal Medicine·H HELLERL SHERF
Jan 1, 1961·Pathologia et microbiologia·H HELLERM PRAS
Jul 12, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·I F N HungK Y Yuen
Jun 21, 2006·Proceedings of the National Academy of Sciences of the United States of America·Jae Jin ChaeDaniel L Kastner
Jun 6, 2007·Annals of Internal Medicine·Rakiba BelkhirThomas Hanslik
Jun 8, 2007·The New England Journal of Medicine·Helen J LachmannPhilip N Hawkins
Jun 26, 2007·European Journal of Pediatrics·Lorenzo CalligarisAlessandro Ventura
Oct 16, 2007·Annals of the Rheumatic Diseases·Loes M KuijkWillem J D Hofhuis
Jun 11, 2008·Joint, Bone, Spine : Revue Du Rhumatisme·Rosa RoldanEduardo Collantes
Aug 12, 2008·Annals of Human Genetics·V P PapadopoulosK Ritis
Nov 27, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Christian MoserJosef Kovarik
Apr 14, 2010·Rheumatology International·Nilüfer AlpayAhmet Gül
Dec 17, 2010·The Journal of Rheumatology·Seza OzenMeral Calguneri
Feb 1, 2011·Seminars in Arthritis and Rheumatism·Ulrich MeinzerIsabelle Koné-Paut
Jul 12, 2011·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Michael MullinsPrabha Ranganathan
Sep 21, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Katia Stankovic StojanovicGilles Grateau
Sep 29, 2011·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Sule Apras BilgenMeral Calguneri
Mar 10, 2012·Rheumatology·Duygu Ovunc Hacihamdioglu, Seza Ozen
Jul 4, 2012·Annals of the Rheumatic Diseases·Nienke Ter HaarUNKNOWN Paediatric Rheumatology International Trials Organisation (PRINTO) and the Eurofever/Eurotraps Projects
Aug 11, 2012·Autoimmunity Reviews·Alessandra Soriano, Raffaele Manna
Jan 17, 2013·Clinical Reviews in Allergy & Immunology·Alessandra SorianoRaffaele Manna
Jan 1, 2014·Current Opinion in Rheumatology·Lisa K Stamp
Feb 19, 2014·Modern Rheumatology·Rıdvan MercanBerna Goker
Apr 8, 2014·International Journal of Rheumatic Diseases·Meltem A Melikoglu, Kazim Senel
Sep 13, 2014·Clinical Rheumatology·Z Birsin OzçakarFatoş Yalçınkaya
Mar 12, 2015·Orphanet Journal of Rare Diseases·Linda Rossi-SemeranoUNKNOWN MAIL1 (Maladies Auto-inflammatoires et Anti-IL-1) study Group on behalf of CRI (Club Rhumatisme et Inflammation)
Mar 12, 2015·Current Medicinal Chemistry·Betul Sozeri, Ozgur Kasapcopur
May 7, 2015·Drug Design, Development and Therapy·Mirella Alpa, Dario Roccatello
May 24, 2015·Rheumatology International·Fehime Kara ErogluSeza Ozen
Aug 8, 2015·Clinical Nephrology·Samar Medani, Catherine Wall
Sep 28, 2015·Nefrología : publicación oficial de la Sociedad Española Nefrologia·Ángel M SevillanoManuel Praga

❮ Previous
Next ❯

Citations

Oct 21, 2020·QJM : Monthly Journal of the Association of Physicians·Bugra Han Egeli, Serdal Ugurlu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Related Papers

Clinical Reviews in Allergy & Immunology
Alessandra SorianoR Manna
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Christian MoserJosef Kovarik
© 2021 Meta ULC. All rights reserved